Isolation and characterization of monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen

Journal of Urology

Volumn 160, Issue 6 II, 1998, Pages 2396-2401

  Murphy, Gerald P ^a   Greene, Thomas G ^a   Tino, William T ^a   Boynton, Alton L ^a   Holmes, Eric H ^a  

^a PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

Antibodies; Cell membrane; Monoclonal; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; HYBRIDOMA; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM;

EID: 0032845060     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62198-0     Document Type: Article

References (27)

1. Israeli, R. S., Powell, C. T., Fair, W. R. and Heston, W. D. W.: Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53: 227, 1993.
2. Horoszewicz, J. S., Kawinski, E. and Murphy, G. P.: Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res., 7: 927, 1987.
3. Troyer, J. K., Beckett, M. L. and Wright, G. L., Jr.: Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int. J. Cancer, 62: 552, 1995.
4. Lopes, A. D., Davis, W. L., Rosenstraus, M. J., Uveges, A. J. and Gilman, S. C.: Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5. Cancer Res., 50: 6423, 1990.
5. Rosenstraus, M. J., Davis, W. J., Lopes, A. D., D'Aleo, C. and Gilman, S.: In vitro and in vivo reactivity of anti-prostate monoclonal antibody immunoconjugate 7E11.C5.3-GYK-DTPA. Antibody Immunoconjugates Radiopharmaceut., 3: 54, 1990.
6. Silver, D. A., Pellicer, I., Fair, W. R., Heston, W. D. W. and Cordon-Cardo, C.: Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin. Cancer Res., 3: 81, 1997.
7. Bostwick, D. G., Pacelli, A., Blute, M., Roche, P. and Murphy, G. P.: Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: study of 184 cases. Cancer, 82: 2256, 1998.
8. Troyer, J. K., Feng, Q., Beckett, M. L. and Wright, G. L.: Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen. Urol. Oncol., 1: 29, 1995.
9. Diamond, S. M., Fair, W. R. and Heston, W. D. W.: Modulation of prostate specific membrane antigen (PSM) expression in vitro by cytokines and growth factors. J. Urol., part 2, 153: 382A, abstract 614, 1995.
10. Wright, G. L., Jr., Grob, M., Haley, C., Grossman, K., Newhall, K., Petrylak, D., Troyer, J., Konchuba, A., Schellhammer, P. F. and Moriarty, R.: Upregulation of prostate-specific antigen after androgen deprivation therapy. Urology, 48: 326, 1996.
11. Kawakami, M. and Nakayama, J.: Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization. Cancer Res., 57: 2321, 1997.
12. Rinker-Schaeffer, C. W., Hawkins, A. L., Su, S. L., Israeli, R. S., Griffin, C. A., Isaacs, J. T. and Heston, W. D.: Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11. Genomics, 30: 105, 1995.
13. Leek, J., Lench, N., Maraj, B., Bailey, A., Carr, I. M., Andersen, S., Cross, J., Whelan, P., MacLennan, K. A., Meredith, D. M. and Markham, A. F.: Prostate-specific membrane antigen: evidence for existence of a second related human gene. Brit. J. Cancer, 72: 583, 1995.
14. 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356). Prostate, 18: 229, 1991.
15. Abdel-Nabi, H., Wright, G. L., Gulfo, J. V., Petrylak, D. P., Neal, C. E., Texter, J. E., Begun, F. P., Tyson, I., Heal, A., Mitchell, E., Purnell, G. and Harwood, S. J.: Monoclonal antibodies and radioimmunoconjugates in the diagnosis and treatment of prostate cancer. Sem. Urol., 10: 45, 1992.
16. 111indium-labeled monoclonal antibody CYT-356. J. Urol., 152: 1952, 1994.
17. Haseman, M. K., Reed, N. L. and Rosenthal, S. A.: Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen: positron emission tomography and biopsy correlation. Clin. Nucl. Med., 21: 703, 1996.
18. Murphy, G., Ragde, H., Kenny, G., Barren, R., Erickson, S., Tjoa, B., Boynton, A., Holmes, E., Gilbaugh, J. and Douglas, T.: Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patients. Anti-cancer Res., 15: 1473, 1995.
19. Murphy, G. P., Maguire, R. T., Rogers, B., Partin, A. W., Nelp, W. B., Troychak, M. J., Ragde, H., Kenny, G. M., Barren, R. J., Bowes, V. A., Gregorakis, A. K., Holmes, E. H. and Boynton, A. L.: Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patients. Prostate, 33: 281, 1997.
20. Murphy, G. P., Tino, W. T., Holmes, E. H., Boynton, A. L., Erickson, S. J., Bowes, V. A., Barren, R. J., Tjoa, B. A., Misrock, S. L., Ragde, H. and Kenny, G. M.: Measurement of prostate-specific membrane antigen in the serum with a new antibody. Prostate, 28: 266, 1996.
21. Oi, V. T. and Herzenberg, L. A.: Immunoglobulin-producing hybrid cell lines. In: Selected Methods in Cellular Immunology. Edited by B. B. Mishell and S. Shiigi. New York: Freeman, pp. 351-372, 1980.
22. Grauer, L. S., Pusateri, K. D., Marignac, J. and Wolfert, R. L.: Identification of PSM protein in cytoplasm of the prostate carcinoma cell line, LNCaP. Proc. Amer. Assn. Cancer Res., 39: 554, 1998.
23. Su, S. L., Huang, I. P., Fair, W. R., Powell, C. T. and Heston, W. D. W.: Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res., 55: 1441, 1995.
24. Holmes, E. H., Greene, T. G., Tino, W. T., Boynton, A. L., Aldape, H. C., Misrock, S. L. and Murphy, G. P.: Analysis of glycosylation of prostate-specific membrane antigen derived from LN-CaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients. Prostate, suppl., 7: 25, 1996.
25. Murphy, G., Tjoa, B., Ragde, H., Kenny, G. and Boynton, A.: Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. Prostate, 29: 371, 1996.
26. Tjoa, B. A., Erickson, S. J., Bowes, V. A., Ragde, H., Kenny, G. M., Cobb, R. C., Ireton, O. E., Troychak, M. J., Boynton, A. L. and Murphy, G. P.: Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. Prostate, 32: 272, 1997.
27. Liu, H., Moy, P., Kim, S., Xia, Y., Rajasekaran, A., Navarro, V., Knudsen, B. and Bander, N. H.: Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res., 57: 3629, 1997.